MktsMarkets

Agios Pharmaceuticals, Inc.
NASDAQ: AGIOKey statistics
AGIO News
Stories mentioning AGIO from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 20,746 | 19,967 | 12,880 | 12,455 | 8,726 | 10,730 | 8,964 | 8,615 |
| Cost of Goods Sold | 1,319 | 1,879 | 1,679 | 1,702 | 1,085 | 1,260 | 783.00 | 1,495 |
| Gross Profit | 19,427 | 18,088 | 11,201 | 10,753 | 7,641 | 9,470 | 8,181 | 7,120 |
| Operating Expenses | ||||||||
| Research & Development | 81,148 | 88,056 | 86,796 | 91,940 | 72,743 | 82,810 | 72,455 | 77,401 |
| Sales General & Admin | 48,304 | 51,610 | 41,274 | 45,869 | 41,527 | 51,697 | 38,537 | 35,536 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (110,025) | (121,578) | (116,869) | (127,056) | (106,629) | (125,037) | (102,811) | (105,817) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 119.00 | 113.00 | 67.00 | 523.00 | 1,253 | 1,623 | 1,651 | 1,579 |
| Pretax Income | (103,433) | 1,001,035 | ||||||
| Tax Provision | 0.00 | 53,120 | ||||||
| Net Income (Loss) | (99,111) | (108,039) | (103,433) | (112,020) | (89,289) | (96,523) | 947,915 | (96,118) |
| Earnings Per Share (Basic) | (1.69) | (1.86) | (1.78) | (1.93) | (1.55) | (1.70) | 16.65 | (1.69) |
| Earnings Per Share (Diluted) | (1.69) | (1.86) | (1.78) | (1.93) | (1.55) | (1.67) | 16.22 | (1.69) |
| Weighted Average Shares Outstanding (Basic) | 58,782 | 57,972 | 58,139 | 57,933 | 57,459 | 56,807 | 56,939 | 56,803 |
| Weighted Average Shares Outstanding (Diluted) | 58,782 | 57,972 | 58,139 | 57,933 | 57,459 | 57,889 | 58,433 | 56,803 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About AGIO
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is a stock listed on the Nasdaq Stock Market under the ticker symbol AGIO. It last traded at $37.19 (Oct 22, 2026, 4:00 PM ET), up 0.0% on the day. That gives Agios Pharmaceuticals a market capitalisation of $2.2B.
Over the past 52 weeks AGIO has traded between $22.24 and $46.00.
Revenue for the quarter ended Mar 31, 2026 was $20.7M; a net loss of $99.1M. Revenue was up 138% from $8.7M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $20.7M | -$99.1M | -477.7% |
| Dec 31, 2025 | $20.0M | -$108.0M | -541.1% |
| Sep 30, 2025 | $12.9M | -$103.4M | -803.1% |
| Jun 30, 2025 | $12.5M | -$112.0M | -899.4% |
From Agios Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…